Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Angelica Cortez

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Leukemia Research|October 5, 2018
TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemiaMaría Sol Brassesco, Julia Alejandra Pezuk, Maria Angelica Cortez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2020
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapyDawei Chen, Roshal R Patel, Vivek Verma, et al.
Research Square|February 24, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Genes, Chromosomes & Cancer|December 23, 2018
Role of miRNAs in immune responses and immunotherapy in cancerMaria Angelica Cortez, Simone Anfossi, Rishab Ramapriyan, et al.
Cancer|February 21, 2013
Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapyVikas Bhardwaj, Tina Cascone, Maria Angelica Cortez, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Frontiers in Oncology|May 19, 2023
Lipid metabolism in tumor immunology and immunotherapyLisa K Duong, Halil Ibrahim Corbali, Thomas S Riad, et al.
Frontiers in Immunology|November 10, 2022
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistanceShonik Ganjoo, Nahum Puebla-Osorio, Selene Nanez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expressionVikas Bhardwaj, Yanai Zhan, Maria Angelica Cortez, et al.
Journal for Immunotherapy of Cancer|January 31, 2020
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trialsDawei Chen, Hari Menon, Vivek Verma, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Leukemia Research|October 5, 2018
TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemiaMaría Sol Brassesco, Julia Alejandra Pezuk, Maria Angelica Cortez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2020
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapyDawei Chen, Roshal R Patel, Vivek Verma, et al.
Research Square|February 24, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Genes, Chromosomes & Cancer|December 23, 2018
Role of miRNAs in immune responses and immunotherapy in cancerMaria Angelica Cortez, Simone Anfossi, Rishab Ramapriyan, et al.
Cancer|February 21, 2013
Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapyVikas Bhardwaj, Tina Cascone, Maria Angelica Cortez, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Frontiers in Oncology|May 19, 2023
Lipid metabolism in tumor immunology and immunotherapyLisa K Duong, Halil Ibrahim Corbali, Thomas S Riad, et al.
Frontiers in Immunology|November 10, 2022
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistanceShonik Ganjoo, Nahum Puebla-Osorio, Selene Nanez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expressionVikas Bhardwaj, Yanai Zhan, Maria Angelica Cortez, et al.
Journal for Immunotherapy of Cancer|January 31, 2020
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trialsDawei Chen, Hari Menon, Vivek Verma, et al.
Pageof 7